Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...About 40 per cent of the votes cast at the group’s annual meeting in 2021 were against the remuneration plan, which is set every three years....
...Health commissioner Stella Kyriakides is pushing the plan after lobbying from health ministers following last winter’s shortages. Painkillers for children were among those affected....
...Przybelski, at UW Health, said about half his patients were initially refused by Medicare Advantage plans for PET scan coverage, adding that “it normally involves a long phone call” to get scans approved...
...J&J’s medtech division has outstripped the growth of the company’s drugs and diagnostics business, generating $30.4bn in sales last year, or 35 per cent of group revenues....
...The positive data will also be a boon to Eli Lilly’s efforts to push for more widescale coverage of the drugs by private insurers and US federal health insurance programme Medicare, which were both initially...
...Others in the sector were down more than 3 per cent, including Solventum, the healthcare group that was spun out from 3M earlier this week....
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...Aardvark plans to use the proceeds from its pre-IPO round to fund a late-stage clinical study into ARD-101’s efficacy on Prader-Willi patients and into patients withdrawing from GLP-1 drugs after weight...
...However, his exit was seen as inevitable from early in his tenure when shareholders privately rebuffed a plan to offer him a $10mn bonus, according to people with knowledge of the plan....
...The group had a market value of $600mn, as of market close on Friday....
...It has abandoned plans for two treatments already. It is working on developing a once-a-day version of its own obesity pill danuglipron after dropping plans for a twice-daily pill....
...I’ve got another meeting with Wes Streeting and Peter Kyle about AI in the health service tomorrow. Feel like I am making headway....
...“We’re positioning the company for the long-term health of the business and the market doesn’t necessarily operate that way,” she said....
...The group is set to hold a town hall for staff on the US situation on Wednesday....
...“The next few days will be crucial because at the moment there’s no plan,” they said....
...Matthew Taylor, chief executive of the NHS Confederation, which represents health groups across the country, said the £3.4bn additional investment in technology over the next parliament had the potential...
...A senior EU court adviser has said the European Commission was wrong to block gene sequencing group Illumina’s $8bn acquisition of Grail and that the decision should be scrapped....
...The shares fell about 8 per cent to €26 on Tuesday, giving the group a market value of €25.6bn....
...US data analytics group Palantir has secured an NHS England contract worth £330mn to develop a new patient data platform, the health service announced on Tuesday....
...Menopause has risen up employers’ agenda as acceptance grows that once-private issues, such as mental health, have an impact on working life....
...The UK government has told the country’s port authorities that it will not “turn on” critical health and safety checks for EU imports when post-Brexit border controls begin this month because of the risk...
...In March, officials from 194 countries came together to agree on a global plan to deal with a threat known as “Disease X”....
...A decade later, that difference had reached more than two-thirds, the group said. “Europe is losing R&D....
...Joe Biden, his Democratic successor, reversed the plan....
International Edition